The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27516, United States
NCT Number: NCT03619161
Purpose: Evaluate the impact of cleaning the bathroom environment on the severity of eczema. Determine if part of the efficacy of bleach baths may be in cleaning the bathroom. Record data on the process in order to improve future interventions.
Participants: Patients and families with eczema
Procedures (methods):
* Obtain baseline eczema severity scores and bacterial cultures from bathtubs * Randomize subjects to receive (1) a bathtub culture alone; (2) a culture and bathroom cleaning; and (3) a culture, cleaning, and bleach baths. * Measure changes in eczema severity scores over 4 weeks * Qualitatively evaluate the process by participants and investigators
Looking for future studies?
Notify Me6 month–17 year
All sexes
Interventional
Not applicable
Chapel Hill, North Carolina, 27516, United States
The study will evaluate the effect of two interventions.
There will be four quantitative assessment phases:
There will be one qualitative assessment:
Additionally, the study team will keep field notes documenting perceptions and experiences during the cleaning process. These qualitative documents will be used for process evaluation to improve home hygiene interventions and studies. Domains that the investigators will assess in field notes include:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All bathrooms with showers or bathtubs will be cleansed with simple products (dilute bleach, dilute white vinegar, baking soda, and dilute Dawn dish soap)
Other names: cleaning
All bathrooms with showers or bathtubs will be cleansed with simple products (dilute bleach, dilute white vinegar, baking soda, and dilute Dawn dish soap).
Other names: cleaning, bleach bath
Time frame: Baseline (day 0) to Week 4 (day 28)
POEM is a 7-item questionnaire that assesses disease symptoms (dryness, itching, flaking, cracking, sleep loss, bleeding, and weeping) with a scoring system of 0 (absent disease) to 28 (severe disease). A higher POEM score correlates with a poorer quality of life (QOL).
University of North Carolina, Chapel Hill
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03293030
Atopic Dermatitis, Atopic Dermatitis Eczema
San Francisco, California, United States
View Trial DetailsNCT05990725
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Augsburg, Germany
View Trial DetailsNCT07703215
Antioxidant Capacity, Atopic Dermatitis
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT07537751
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
View Trial Details